comparemela.com
Home
Live Updates
Mycrodose Therapeutics Receives US DEA Schedule I License to Research Four (4) Psychedelic Compounds : comparemela.com
Mycrodose Therapeutics Receives US DEA Schedule I License to Research Four (4) Psychedelic Compounds
San Diego, California (PRWEB) August 20, 2021 -- Mycrodose Therapeutics is pleased to announce that the company has been approved by the United States Drug
Related Keywords
State Of California
,
California
,
United States
,
San Diego
,
Patrick Eckstrom
,
Frank Kochinke
,
Research Advisory Board
,
Us Food Drug Administration
,
United States Drug Enforcement Agency
,
Mycrodose Therapeutics An Advanced Drug Delivery Company
,
Mycrodose Therapeutics
,
Advanced Drug Delivery
,
Chief Science
,
California Attorney General
,
Drug Administration
,
Mycrodose Therapeutic
,
Schedulei License
,
Chad Conner
,
Chief Executive
,
Operating Officer
,
Press Release
,
comparemela.com © 2020. All Rights Reserved.